Characterization of Cardiovascular Risk Profile and Therapeutic Management in Patients With Type 2 Diabetes Mellitus in Italy

Recruiting now

Conditions studied: Type 2 Diabetes

In brief

CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.

Key facts

Study ID

NCT07375069

Run by

Federico II University

People needed

3000

Starts

2022-10-01

Expected to finish

2027-10-31

Last updated by the study team

2026-03-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years;
• Diagnosis of type 2 diabetes mellitus (T2DM);
• Stable clinical conditions
• Outpatient settings
• Ability to understand the study procedures and provide written informed consent.

You may not qualify if…

• Patients with type 1 diabetes mellitus;
• Active participation in interventional studies;
• Any condition that may put the patient at risk by participating in the study.

Where it is running

• Federico II University of Naples, Department of Advanced Biomedical Sciences — Naples, Napoli, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.